SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : One trade a week

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Mike McFarland who wrote (46)4/1/1999 12:45:00 PM
From: Mike McFarland   of 89
 
CTII--CytoTherapeutics
(encapsulated cell and stem cell area)
A very "sexy" area indeed, this is the
type of stock that will absolutely fly
on a news event, the traders seem to know
the symbol, and somebody had it as their
pick for the year--some traders newsletter.
At one point I had loaded up on quite a few
shares...since then I came to my senses and
pared things back to sort of an averaged-sized
position for me of just a fewK of shares.

GMED which has merged with Megabios seems to
jumped through the necessary hoops to survive
for awhile. Fits in with my gene therapy angle.
The new company will be called Valentis.

Hyseq-just a dart. Hey, I'm a gambler. Oh I've
read the Yahoo and SI threads, but I really
don't know very much about the DNA chip business.
Seems like it will be a very exciting area in
the years ahead...could have just bought affx,
but that would not be in my character to go for
something obvious (and perhaps fairly priced).

Hyseq, with its partner, PE Corporation
(formerly known as The Perkin-Elmer Corporation)
offers the only universal sequencing chip through
their HyChip(TM) Early Access Program.

Information about Hyseq is available on the WWW
at hyseq.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext